Holland et al in JAMA: Clinical Management of Staphylococcus aureus Bacteremia
Thomas Holland, MD, medical instructor in the Division of Infectious Diseases and hospitalist at Duke University Hospital, coauthored a JAMA review of evidence of management strategies for S aureus bacteremia to determine whether transesophageal echocardiography is necessary in all adult cases and what is the optimal antibiotic therapy for methicillin-resistant S aureus (MRSA) bacteremia. Read the review article.
White House references Duke leadership in antibiotic resistance
The Antibiotic Resistance Leadership Group (ARLG), based at Duke as part of a six-year, $62 million federal grant to Vance Fowler, MD, MHS, and a group of researchers at Duke and across the country (learn more), is mentioned as an important part of a new ex
Heard on the radio: New superbug skyrockets in southeast
Joshua Thaden, MD, fellow in the Division of Infectious Diseases, was interviewed on the NPR show Here and Now about his recent research in Carbapenem-resistant enterobacteriaceae (CRE).
Infectious Diseases recruits Greg Gray, influenza expert and One Health proponent

Grand Rounds 6/27/14: Special presentations by Klotman and Dzau

Duke study of single-dose antibiotic used for bacterial skin infections appears in NEJM
In the battle against stubborn skin infections, including methicillin-resistant Staphylococcus aureus (MRSA), a new single-dose antibiotic is as effective as a twice-daily infusion given for up to 10 days, according to a large study led by Duke Medicine researchers.
Researchers said the advantage of the new drug, oritavancin, is its potential to curtail what has been a key driver of antibiotic resistance: a tendency for patients to stop taking antibiotics once they feel better.
Research Conference 5/30/14: Using Pathogens to Decipher Human Genetic Variation in Disease Susceptibility
[caption id="attachment_15540" align="alignright" width="300"]
The circle plot displays how the same genetic differences can contribute to multiple human traits and diseases.

Grand Rounds 5/23/14: State of the Internal Medicine Residency Program
Medicine Grand Rounds on Fri., May 23 at 8 a.m. in Duke Hospital room 2002 will feature Aimee Zaas, MD, MHS, associate professor of medicine (Infectious Diseases) and Program Director, Internal Medicine Residency Program.
Dr.
Lawrence David gets to the gut of the matter
Head over to Duke Research Blog and check out a podcast featuring Lawrence David, PhD, assistant professor of medicine (Infectious Diseases), molecular genetics and microbiology and the Duke Institute for Genome Sciences. Dr.